The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119809842 11980984 2 F 20151117 20160509 20160129 20160811 PER US-ASTRAZENECA-2016SE06024 ASTRAZENECA 25809.00 DY M Y 111.10000 KG 20160811 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119809842 11980984 1 PS BYDUREON EXENATIDE 1 Subcutaneous 22200 2 MG /wk
119809842 11980984 2 SS BYDUREON EXENATIDE 1 Subcutaneous FJ0044 22200 2 MG /wk
119809842 11980984 3 SS BYDUREON EXENATIDE 1 Subcutaneous FJ0044 22200 2 MG /wk
119809842 11980984 4 SS BYETTA EXENATIDE 1 Subcutaneous U 0 10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
119809842 11980984 5 SS FARXIGA DAPAGLIFLOZIN PROPANEDIOL 1 Oral 10 MG, DAILY IN THE MORNING 0 TABLET
119809842 11980984 6 C METFORMIN METFORMIN HYDROCHLORIDE 1 0
119809842 11980984 7 C FENOFIBRATE. FENOFIBRATE 1 50.0MG UNKNOWN 0 50 MG
119809842 11980984 8 C GLIMEPIRIDE. GLIMEPIRIDE 1 Oral 0 2 MG TABLET BID
119809842 11980984 9 C BABY ASPIRIN ASPIRIN 1 DAILY 0
119809842 11980984 10 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 0 2.5 MG TABLET QD
119809842 11980984 11 C CARVEDILOL. CARVEDILOL 1 Oral 0 25 MG TABLET BID
119809842 11980984 12 C CHLORTHALIDONE. CHLORTHALIDONE 1 Oral 25 MG, 1/2 TABLET, DAILY 0 TABLET
119809842 11980984 13 C COENZYME Q10 UBIDECARENONE 1 0
119809842 11980984 14 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 Sublingual 1000MCG, DAILY 0 TABLET
119809842 11980984 15 C FISH OIL FISH OIL 1 Oral 0
119809842 11980984 16 C GLUCOSAMINE-CHONDROITIN CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE SULFATE 1 Oral 750-600-99-5 MG, TAKE TWO TABLET DAILY 0 TABLET
119809842 11980984 17 C IRBESARTAN. IRBESARTAN 1 Oral 0 300 MG TABLET QD
119809842 11980984 18 C MULTIVITAMIN VITAMINS 1 Oral TAKE 1 TABLET BY ORAL ROUTE DAILY 0 TABLET
119809842 11980984 19 C ONE TOUCH ULTRA TEST MISCELLANEOUS STRIP 2 USE AS DIRECTED THREE TIMES A DAY DX-250.02 0
119809842 11980984 20 C TESTOSTERONE. TESTOSTERONE 1 Transdermal 120 MG, DAILY 0
119809842 11980984 21 C VITAMIN C ASCORBIC ACID 1 Oral 0 100 MG TABLET QD
119809842 11980984 22 C ZETIA EZETIMIBE 1 Oral 0 10 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119809842 11980984 1 Type 2 diabetes mellitus
119809842 11980984 2 Type 2 diabetes mellitus
119809842 11980984 3 Type 2 diabetes mellitus
119809842 11980984 4 Type 2 diabetes mellitus
119809842 11980984 5 Diabetes mellitus
119809842 11980984 6 Diabetes mellitus

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
119809842 11980984 Injection site extravasation
119809842 11980984 Injection site haemorrhage
119809842 11980984 Underdose

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119809842 11980984 1 20151117 0
119809842 11980984 2 20160117 0
119809842 11980984 3 20160425 0
119809842 11980984 5 20150317 0
119809842 11980984 8 20150529 0
119809842 11980984 11 20160415 0
119809842 11980984 19 20150317 0